REGISTERED NUMBER: 11787312 (England and Wales)

Unaudited Financial Statements for the Year Ended 31st January 2025

for

Crosbie Medical Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

2,734

2,819

CURRENT ASSETS

Cash at bank

70,704

77,258

CREDITORS

Amounts falling due within one year

5

2,078

6,081

NET CURRENT ASSETS

68,626

71,177

TOTAL ASSETS LESS CURRENT LIABILITIES

71,360

73,996

PROVISIONS FOR LIABILITIES

194

536

NET ASSETS

71,166

73,460

CAPITAL AND RESERVES

Called up share capital

6

204

204

Retained earnings

70,962

73,256

SHAREHOLDERS' FUNDS

71,166

73,460

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30th September 2025 and were signed on its behalf by:

Dr P Crosbie - Director

1.	COMPANY INFORMATION

Crosbie Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

11787312

Registered office:

The Lexicon

Mount Street

Manchester

M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

fittings

£

COST

At 1st February 2024

5,480

Additions

1,714

At 31st January 2025

7,194

DEPRECIATION

At 1st February 2024

2,661

Charge for year

1,799

At 31st January 2025

4,460

NET BOOK VALUE

At 31st January 2025

2,734

At 31st January 2024

2,819

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.25

31.1.24

£

£

Tax

83

3,737

Directors' current accounts

1,312

1,659

Accrued expenses

683

685

2,078

6,081

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.1.25

31.1.24

value:

£

£

100

Ordinary A

£1

100

100

100

Ordinary B

£1

100

100

4

Ordinary C (1) & D (3)

£1

4

4

204

204

The A and B Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The C and D Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A, B, C and D Shares rank pari passu in respect of dividend and capital distribution rights.

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st January 2025 and 31st January 2024:

31.1.25

31.1.24

£

£

Dr P Crosbie and Dr E Crosbie

Balance outstanding at start of year

(1,659

)

(5,048

)

Amounts advanced

2,375

13,500

Amounts repaid

(2,028

)

(10,111

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(1,312

)

(1,659

)

The loan is repayable on demand and no interest was charged during the period.

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr P Crosbie.